Endocrine Abstracts

Pseudomonas aeruginosa mannose-sensitive-hemagglutinin (PA-MSHA) is a bacteria-mediated cancer therapy showing promise in inhibiting cancer growth by impeding tumor cells and inducing natural cell death. Clinical studies indicate its ability to enhance chemotherapy efficacy and stimulate the immune system against cancer, presenting manageable side effects such as fever and skin irritation. Nevertheless, the safety profile of PA-MSHA requires further exploration, emphasizing th...